RhumbLine Advisers
PIII icon

RhumbLine Advisers’s P3 Health Partners PIII Stock Holding History

RhumbLine Advisers’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-279
Closed -$6.27K – 4299
2024
Q2 		$6.27K Sell
279
-595
-68% -$17.8K ﹤0.01% 4051
2024
Q1 		$45K Buy
874
+7
+0.8% +$389 ﹤0.01% 3648
2023
Q4 		$61.1K Buy
867
+19
+2% +$1.31K ﹤0.01% 3580
2023
Q3 		$62.3K Buy
848
+58
+7% +$6.02K ﹤0.01% 3598
2023
Q2 		$118K Buy
790
+122
+18% +$16.9K ﹤0.01% 3457
2023
Q1 		$35K Buy
668
+8
+1% +$481 ﹤0.01% 2920
2022
Q4 		$61K Buy
660
+7
+1% +$1.52K ﹤0.01% 2942
2022
Q3 		$151K Buy
653
+32
+5% +$8K ﹤0.01% 2947
2022
Q2 		$116K Buy
+621
New +$173K ﹤0.01% 3021

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RhumbLine Advisers's PIII Position: Q3 2024 in Review

RhumbLine Advisers sold out of P3 Health Partners (PIII) in Q3 2024, closing a stake of 279 shares — an estimated $6.27K sold.

RhumbLine Advisers first reported a position in PIII in Q2 2022 and held it in 9 quarters. The position peaked at $151K in Q3 2022. 46 funds tracked by Wall St. Rank hold PIII as of Q3 2024.

  • RhumbLine Advisers reported no remaining P3 Health Partners position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 279 P3 Health Partners shares in Q3 2024, an estimated $6.27K.
  • RhumbLine Advisers first reported a position in P3 Health Partners in Q2 2022 and held it in 9 quarters.
  • RhumbLine Advisers's P3 Health Partners position peaked at $151K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.